Episode 253: Patients' Perspectives on Adjuvant and 1st Line RCC

By The Uromigos - Last Updated: September 19, 2023

Rachel Giles, MD, PhD, describes her patient data on adjuvant and first line treatments in renal cell carcinoma.
Dr. Giles is the Chief Executive Officer of the International Kidney Cancer Coalition.

Post Tags:Uromigos-Kidney Cancer
Advertisement
Advertisement
Advertisement